Grant: Planning and Dissemination Grant - Institute Community Support
Université de Sherbrooke
$15,000.00
Permissive hypotension to reduce organ injury - The OVATION-65 trial
FY 2016-17
Summary
The OVATION-65 trial addresses the daily challenge that ICU clinicians (doctors/nurses) face when treating patients with low blood pressure (also known as shock). These clinicians must balance the risks of low blood pressure with the risks of harm from drugs (called vasopressors) used to treat this condition. In these patients, shock is common and can be lethal. Clinical research to guide the use of vasopressors is lacking, but these drugs can have devastating side effects, especially in older patients.
Permissive low blood pressure is defined as the acceptance of blood pressure targets below conventional levels to reduce dose and duration of vasopressors. This strategy is proposed to reduce the risk of vasopressor-induced harm while still avoiding very low blood pressure. Growing interest in permissive low blood pressure echoes the benefits associated with other 'permissive' targets in critical care that are less guided by normal values and are associated with improved survival.
We have designed OVATION-65 to evaluate the effects of permissive low blood pressure on survival in a older patients. Because more patients will be needed than can be enrolled in any one country, we propose a collaboration between two high profile research networks in critical care: Canadian Critical Care Trials Group (CCCTG) and Intensive Care National Audit and Research Centre (ICNARC, United Kingdom). A parallel objective is to use blood tests to determine the effects of permissive low blood pressure on different organs.
The objectives of the proposed meeting in June 2017 are two-fold:
1)Conduct a study initiation meeting with Canadian investigators and research coordinators to review objectives, protocol and study procedures.
2)Conduct a planning meeting to draft the terms of engagement and protocol of the combined analysis at the end of the OVATION-65 Trial in Canada and the 65 Trial in the UK.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
365685
Name
Lamontagne Francois
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Planning and Dissemination - ICRH
Projecttitle
Permissive hypotension to reduce organ injury - The OVATION-65 trial
Programtype2
Miscellaneous Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Cardiovascular; Critical Care; Vasopressors
Abstract
The OVATION-65 trial addresses the daily challenge that ICU clinicians (doctors/nurses) face when treating patients with low blood pressure (also known as shock). These clinicians must balance the risks of low blood pressure with the risks of harm from drugs (called vasopressors) used to treat this condition. In these patients, shock is common and can be lethal. Clinical research to guide the use of vasopressors is lacking, but these drugs can have devastating side effects, especially in older patients.
Permissive low blood pressure is defined as the acceptance of blood pressure targets below conventional levels to reduce dose and duration of vasopressors. This strategy is proposed to reduce the risk of vasopressor-induced harm while still avoiding very low blood pressure. Growing interest in permissive low blood pressure echoes the benefits associated with other 'permissive' targets in critical care that are less guided by normal values and are associated with improved survival.
We have designed OVATION-65 to evaluate the effects of permissive low blood pressure on survival in a older patients. Because more patients will be needed than can be enrolled in any one country, we propose a collaboration between two high profile research networks in critical care: Canadian Critical Care Trials Group (CCCTG) and Intensive Care National Audit and Research Centre (ICNARC, United Kingdom). A parallel objective is to use blood tests to determine the effects of permissive low blood pressure on different organs.
The objectives of the proposed meeting in June 2017 are two-fold:
1)Conduct a study initiation meeting with Canadian investigators and research coordinators to review objectives, protocol and study procedures.
2)Conduct a planning meeting to draft the terms of engagement and protocol of the combined analysis at the end of the OVATION-65 Trial in Canada and the 65 Trial in the UK.
Competitiondate
201702
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lamontagne, Francois; Adhikari, Neill K
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $15,000~ $0~